Evidence map›Paper›PMID 42496856›Full record

ArticleSports medicine (Auckland, N.Z.)2026

Dietary FODMAP Manipulation for Exercise-Associated Gastrointestinal Symptoms: Why Symptom Severity Should Guide Our Approach.

Rachel Scrivin, Natália Vilela Silva Daniel, Gary Slater, Ricardo J S Costa

Abstract read
PubMed Publisher
In one paragraph

Article in Sports medicine (Auckland, N.Z.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rachel ScrivinFaculty of Sport and Health, Toi Ohomai Institute of Technology, Tauranga, New Zealand. Rachel.Scrivin@toiohomai.ac.nz.ORCID http://orcid.org/0000-0003-4293-1834
Natália Vilela Silva DanielFaculdade de Ciências Aplicadas, Universidade Estadual de Campinas, Limeira, SP, Brazil.ORCID http://orcid.org/0000-0002-8959-943X
Gary SlaterSchool of Health, University of the Sunshine Coast, Sippy Downs, QLD, Australia.ORCID http://orcid.org/0000-0003-2753-7847
Ricardo J S CostaFaculty of Medicine Nursing and Health Sciences, Department of Nutrition Dietetics and Food, Monash University, Melbourne, VIC, Australia.ORCID http://orcid.org/0000-0003-3069-486X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exercise-induced gastrointestinal syndrome (EIGS) is a well-defined term that describes disruptions to gastrointestinal integrity and function that occur during exercise. A commonly reported outcome of EIGS is exercise-associated gastrointestinal symptoms (Ex-GIS), including flatulence, lower abdominal bloating and pain, and urge to defecate, which can compromise comfort, training quality and race-day execution. Low-fermentable oligo-, di-, mono-saccharide and polyol (FODMAP) diets are effective at reducing gastrointestinal symptoms in individuals with irritable bowel syndrome and, owing to similarities in symptom presentation, have increasingly been used by athletes to better manage Ex-GIS. This Current Opinion article argues that FODMAP manipulation should be used strategically rather than as a routine dietary default. For athletes with severe Ex-GIS, a short-term low-FODMAP approach may help attenuate symptoms around key training sessions and/or competition. In contrast, athletes with mild or infrequent symptoms may benefit from a more liberal FODMAP intake that mitigates disruptions to gastrointestinal integrity and potentially EIGS outcomes while avoiding unnecessary dietary restriction. However, neither approach has consistently been shown to improve performance. Accordingly, any modification of FODMAP intake should be individualized and guided by likely underlying primary mechanisms, symptom severity, exercise demands, and the need to maintain overall dietary adequacy.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.